Next week, the plan initiated by the Commission to make assessments of research more meaningfully reflect its impact and value will open up to signatories. Then the hard work of translating it to action on the ground will begin
At a Science|Business conference Sept. 7, Commissioner Gabriel and other policymakers debated actions to exploit the EU’s full research and innovation capacity – and Science|Business launched its own Widening initiative
With a new prime minister in power, the UK is making a fresh overture to convince the Commission to let association to the research programme go ahead. UK universities are calling for an end to the ‘toxic uncertainty’
Research infrastructures are worried about the rising cost of running large scientific experiments and are looking for help with paying sky-high electricity bills. One lab has seen a 60% increase in its tariff this year
At a Science|Business conference Sept. 7, global science leaders debated whether and how to deal with Russia. Watch the highlights video, and take the survey
In the name of competition, the European Commission wants to stop the US DNA sequencing company from buying a US leader in applying DNA sequencing to novel cancer diagnostics. The view from the ground in Europe is that it may not matter so much
With fertiliser shortages, drought and declining soil fertility threatening agricultural production in Europe, there is increased pressure to relax EU rules on the use of genome editing in plant breeding
It can provide answers, but science alone will not deliver on sustainable development goals, says Maria Leptin in a reality check on ‘scientific populism’
Financing is part of a financing portfolio worth over €15B to encourage companies to invest in climate change-related technologies and end Europe’s dependence on imports of fossil fuel from Russia
European policy encourages researchers to move freely between borders, but blanket EU labour rules are getting in the way. With pandemic travel restrictions lifted the administration costs are giving institutions a headache
As elections near, Biden promotes ‘whole-of-government’ effort to cut cancer death rates and strengthen the biopharma and biotech sectors. International partners welcome, up to a point
The EU succeeded in creating a portfolio of vaccines and procuring enough doses to go round, but contracts did not make provisions for disruptions to supplies
Receive the Funding Newswire each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.